Mandate

Vinge advises Capio in connection with acquisition of Backa Läkarhus

January 05, 2017

Capio Närsjukvård AB, a wholly owned subsidiary of Capio AB (publ) listed on Nasdaq Stockholm, has entered into an agreement for the acquisition of all shares in Backa Läkarhus AB which conducts operations through eleven district health centres and nine rehabilitation centres in the Västra Götaland Region and Region Halland.

The operations had a turnover of approximately MSEK 345 in 2016, and have 83 000 listed patients. Closing is subject to customary closing conditions from the relevant county councils and unconditional approval from the Swedish Competition Authority. The enterprise value amounts to MSEK 300.

Vinge’s team primarily consists of client responsible partner Anders Strid, Frida Bäckegren (project leader M&A), Lina André and Jonas Lindblad (employment), Gabriella Fossum (procurement), Mercedes Anderås (real estate), Camilla Andersson (corporate) as well as Pär Remnelid, among others (competition).

Related

Vinge advises Axcel in connection with the sale of Loopia Group to team.blue

Vinge advises Axcel V in connection with the sale of Loopia Group to team.blue, Europe’s leading digital enabler for entrepreneurs and SMBs and backed by Hg, a leading investor in European and transatlantic software and services businesses.
May 23, 2024

Vinge advises Humana in its acquisition of Team Olivia Norge AS

Humana Group ("Humana") strengthens its offering of high-quality care services in Norway as Human Care Holding AS ("Humana Norway") has entered into an agreement to acquire Team Olivia Norge AS for a purchase price of million SEK 341 on a cash- and debt-free basis.
May 17, 2024

Vinge advises Stendörren in connection with issuance of green capital securities and tender offer

Vinge has advised Stendörren Fastigheter AB in connection with its issuance of green subordinated and perpetual capital securities in an amount of SEK 300 million (within a framework of SEK 400 million) and its parallel tender offer in respect of its previously issued capital securities.
May 17, 2024